Breast cancer metastases are molecularly distinct from their primary tumors

M. Vecchi, S. Confalonieri, P. Nuciforo, M. A. Viganò, M. Capra, M. Bianchi, D. Nicosia, F. Bianchi, V. Galimberti, G. Viale, G. Palermo, A. Riccardi, R. Campanini, M. G. Daidone, M. A. Pierotti, S. Pece, P. P. Di Fiore

Research output: Contribution to journalArticle

75 Citations (Scopus)

Abstract

Metastases have been widely thought to arise from rare, selected, mutation-bearing cells in the primary tumor. Recently, however, it has been proposed that breast tumors are imprinted ab initio with metastatic ability. Thus, there is a debate over whether 'phenotypic' disease progression is really associated with 'molecular' progression. We profiled 26 matched primary breast tumors and lymph node metastases and identified 270 probesets that could discriminate between the two categories. We then used an independent cohort of breast tumors (81 samples) and unmatched distant metastases (32 samples) to validate and refine this list down to a 126-probeset list. A representative subset of these genes was subjected to analysis by in situ hybridization, on a third independent cohort (57 primary breast tumors and matched lymph node metastases). This not only confirmed the expression profile data, but also allowed us to establish the cellular origin of the signals. One-third of the analysed representative genes (4 of 11) were expressed by the epithelial component. The four epithelial genes alone were able to discriminate primary breast tumors from their metastases. Finally, engineered alterations in the expression of two of the epithelial genes (SERPINB5 and LTF) modified cell motility in vitro, in accordance with a possible causal role in metastasis. Our results show that breast cancer metastases are molecularly distinct from their primary tumors.

Original languageEnglish
Pages (from-to)2148-2158
Number of pages11
JournalOncogene
Volume27
Issue number15
DOIs
Publication statusPublished - Apr 3 2008

Fingerprint

Breast Neoplasms
Neoplasm Metastasis
Neoplasms
Genes
Lymph Nodes
Cell Movement
In Situ Hybridization
Disease Progression
Mutation

Keywords

  • Breast cancer
  • Gene profiling
  • Metastases

ASJC Scopus subject areas

  • Molecular Biology
  • Cancer Research
  • Genetics

Cite this

Vecchi, M., Confalonieri, S., Nuciforo, P., Viganò, M. A., Capra, M., Bianchi, M., ... Di Fiore, P. P. (2008). Breast cancer metastases are molecularly distinct from their primary tumors. Oncogene, 27(15), 2148-2158. https://doi.org/10.1038/sj.onc.1210858

Breast cancer metastases are molecularly distinct from their primary tumors. / Vecchi, M.; Confalonieri, S.; Nuciforo, P.; Viganò, M. A.; Capra, M.; Bianchi, M.; Nicosia, D.; Bianchi, F.; Galimberti, V.; Viale, G.; Palermo, G.; Riccardi, A.; Campanini, R.; Daidone, M. G.; Pierotti, M. A.; Pece, S.; Di Fiore, P. P.

In: Oncogene, Vol. 27, No. 15, 03.04.2008, p. 2148-2158.

Research output: Contribution to journalArticle

Vecchi, M, Confalonieri, S, Nuciforo, P, Viganò, MA, Capra, M, Bianchi, M, Nicosia, D, Bianchi, F, Galimberti, V, Viale, G, Palermo, G, Riccardi, A, Campanini, R, Daidone, MG, Pierotti, MA, Pece, S & Di Fiore, PP 2008, 'Breast cancer metastases are molecularly distinct from their primary tumors', Oncogene, vol. 27, no. 15, pp. 2148-2158. https://doi.org/10.1038/sj.onc.1210858
Vecchi M, Confalonieri S, Nuciforo P, Viganò MA, Capra M, Bianchi M et al. Breast cancer metastases are molecularly distinct from their primary tumors. Oncogene. 2008 Apr 3;27(15):2148-2158. https://doi.org/10.1038/sj.onc.1210858
Vecchi, M. ; Confalonieri, S. ; Nuciforo, P. ; Viganò, M. A. ; Capra, M. ; Bianchi, M. ; Nicosia, D. ; Bianchi, F. ; Galimberti, V. ; Viale, G. ; Palermo, G. ; Riccardi, A. ; Campanini, R. ; Daidone, M. G. ; Pierotti, M. A. ; Pece, S. ; Di Fiore, P. P. / Breast cancer metastases are molecularly distinct from their primary tumors. In: Oncogene. 2008 ; Vol. 27, No. 15. pp. 2148-2158.
@article{200fb358ea4942a292f8b7e11699100d,
title = "Breast cancer metastases are molecularly distinct from their primary tumors",
abstract = "Metastases have been widely thought to arise from rare, selected, mutation-bearing cells in the primary tumor. Recently, however, it has been proposed that breast tumors are imprinted ab initio with metastatic ability. Thus, there is a debate over whether 'phenotypic' disease progression is really associated with 'molecular' progression. We profiled 26 matched primary breast tumors and lymph node metastases and identified 270 probesets that could discriminate between the two categories. We then used an independent cohort of breast tumors (81 samples) and unmatched distant metastases (32 samples) to validate and refine this list down to a 126-probeset list. A representative subset of these genes was subjected to analysis by in situ hybridization, on a third independent cohort (57 primary breast tumors and matched lymph node metastases). This not only confirmed the expression profile data, but also allowed us to establish the cellular origin of the signals. One-third of the analysed representative genes (4 of 11) were expressed by the epithelial component. The four epithelial genes alone were able to discriminate primary breast tumors from their metastases. Finally, engineered alterations in the expression of two of the epithelial genes (SERPINB5 and LTF) modified cell motility in vitro, in accordance with a possible causal role in metastasis. Our results show that breast cancer metastases are molecularly distinct from their primary tumors.",
keywords = "Breast cancer, Gene profiling, Metastases",
author = "M. Vecchi and S. Confalonieri and P. Nuciforo and Vigan{\`o}, {M. A.} and M. Capra and M. Bianchi and D. Nicosia and F. Bianchi and V. Galimberti and G. Viale and G. Palermo and A. Riccardi and R. Campanini and Daidone, {M. G.} and Pierotti, {M. A.} and S. Pece and {Di Fiore}, {P. P.}",
year = "2008",
month = "4",
day = "3",
doi = "10.1038/sj.onc.1210858",
language = "English",
volume = "27",
pages = "2148--2158",
journal = "Oncogene",
issn = "0950-9232",
publisher = "Nature Publishing Group",
number = "15",

}

TY - JOUR

T1 - Breast cancer metastases are molecularly distinct from their primary tumors

AU - Vecchi, M.

AU - Confalonieri, S.

AU - Nuciforo, P.

AU - Viganò, M. A.

AU - Capra, M.

AU - Bianchi, M.

AU - Nicosia, D.

AU - Bianchi, F.

AU - Galimberti, V.

AU - Viale, G.

AU - Palermo, G.

AU - Riccardi, A.

AU - Campanini, R.

AU - Daidone, M. G.

AU - Pierotti, M. A.

AU - Pece, S.

AU - Di Fiore, P. P.

PY - 2008/4/3

Y1 - 2008/4/3

N2 - Metastases have been widely thought to arise from rare, selected, mutation-bearing cells in the primary tumor. Recently, however, it has been proposed that breast tumors are imprinted ab initio with metastatic ability. Thus, there is a debate over whether 'phenotypic' disease progression is really associated with 'molecular' progression. We profiled 26 matched primary breast tumors and lymph node metastases and identified 270 probesets that could discriminate between the two categories. We then used an independent cohort of breast tumors (81 samples) and unmatched distant metastases (32 samples) to validate and refine this list down to a 126-probeset list. A representative subset of these genes was subjected to analysis by in situ hybridization, on a third independent cohort (57 primary breast tumors and matched lymph node metastases). This not only confirmed the expression profile data, but also allowed us to establish the cellular origin of the signals. One-third of the analysed representative genes (4 of 11) were expressed by the epithelial component. The four epithelial genes alone were able to discriminate primary breast tumors from their metastases. Finally, engineered alterations in the expression of two of the epithelial genes (SERPINB5 and LTF) modified cell motility in vitro, in accordance with a possible causal role in metastasis. Our results show that breast cancer metastases are molecularly distinct from their primary tumors.

AB - Metastases have been widely thought to arise from rare, selected, mutation-bearing cells in the primary tumor. Recently, however, it has been proposed that breast tumors are imprinted ab initio with metastatic ability. Thus, there is a debate over whether 'phenotypic' disease progression is really associated with 'molecular' progression. We profiled 26 matched primary breast tumors and lymph node metastases and identified 270 probesets that could discriminate between the two categories. We then used an independent cohort of breast tumors (81 samples) and unmatched distant metastases (32 samples) to validate and refine this list down to a 126-probeset list. A representative subset of these genes was subjected to analysis by in situ hybridization, on a third independent cohort (57 primary breast tumors and matched lymph node metastases). This not only confirmed the expression profile data, but also allowed us to establish the cellular origin of the signals. One-third of the analysed representative genes (4 of 11) were expressed by the epithelial component. The four epithelial genes alone were able to discriminate primary breast tumors from their metastases. Finally, engineered alterations in the expression of two of the epithelial genes (SERPINB5 and LTF) modified cell motility in vitro, in accordance with a possible causal role in metastasis. Our results show that breast cancer metastases are molecularly distinct from their primary tumors.

KW - Breast cancer

KW - Gene profiling

KW - Metastases

UR - http://www.scopus.com/inward/record.url?scp=41649098379&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=41649098379&partnerID=8YFLogxK

U2 - 10.1038/sj.onc.1210858

DO - 10.1038/sj.onc.1210858

M3 - Article

VL - 27

SP - 2148

EP - 2158

JO - Oncogene

JF - Oncogene

SN - 0950-9232

IS - 15

ER -